Drug Patents owned by Pierre Fabre Derma

1. List of Hemangeol drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8338489 PIERRE FABRE DERMA Use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas
Oct, 2028

(5 years from now)

US8987262 PIERRE FABRE DERMA Use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas
Oct, 2028

(5 years from now)

Drugs and Companies using PROPRANOLOL HYDROCHLORIDE ingredient

Market Authorisation Date: 14 March, 2014

Treatment: Method to treat hemangioma.; Method to treat infantile hemangioma

Dosage: SOLUTION;ORAL

How can I launch a generic of HEMANGEOL before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic